Navigation Links
Schering-Plough Announces Transition of Animal Health Leadership
Date:10/17/2008

KENILWORTH, N.J., Oct. 17 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced the transition of leadership of its Animal Health unit from Ruurd Stolp, D.V.M., Ph.D., to Raul E. Kohan, who was previously the Deputy Head of the Animal Health unit. In his role as senior vice president and president, Intervet/Schering-Plough Animal Health, Kohan will continue reporting to Fred Hassan, chairman and chief executive officer.

In this role, Kohan is responsible for overseeing the company's worldwide animal health business, which includes a range of pharmaceuticals, vaccines and services for food-producing and companion animals. The role is based in Boxmeer, the Netherlands, where the Animal Health unit is headquartered.

Kohan joined Schering-Plough in 1984 and has since held positions of increasing responsibility. He recently served as Deputy Head of Animal Health and senior vice president, Corporate Excellence and Administrative Services for Schering-Plough Corporation. Previously, Kohan's responsibilities included overseeing the company's Global Specialty Operations group, which comprised Animal Health and Consumer Health Care for Schering-Plough.

Kohan graduated from the General San Martin Military Academy, Argentina, and holds an M.B.A. degree in economics from the University of Buenos Aires.

Stolp will transition responsibilities to Kohan over the next several months. During his 21 years with Intervet, Stolp held various roles of increasing responsibility within the Animal Health unit. Previously, Stolp was president of Intervet International, a position he held since 2002.

"Ruurd and Raul played critical leadership roles in our successful combination of Organon BioSciences with
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
2. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
3. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
4. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
5. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
6. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
8. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
9. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
10. Schering-Plough CEO to Buy $2 Million in Common Shares
11. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... has been awarded a three-year $1.7 million grant ... develop new imaging technologies and data analysis techniques ... networks of neurons in the brain interact to ... identify the precise interactions between millions of nerve ... and alterations in these interactions that may be ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 The ... option to help diabetics curb their sweet tooth, but ... Nature this September, suggests that zero-calorie sweeteners may ... 2 diabetes. , The Weizmann Institute of Science ... fed artificial sweeteners to mice, the mice developed glucose ...
(Date:9/30/2014)... Regenerative Medicine Solutions (RMS) is set to open ... RMS welcomes the launch of an entirely new facility, ... new treatment center for the Lung Institute. , ... Nashville, the hope is to bring awareness to those ... undiagnosed. With Nashville being a hub for medical technology, ...
(Date:9/30/2014)... Sept. 30, 2014 (HealthDay News) -- Medicare should cover ... high risk for the disease, a coalition of more ... coalition, which includes the Lung Cancer Alliance, the Society ... American Cancer Society and the American Society of Clinical ... to the U.S. Centers for Medicare & Medicaid Services ...
(Date:9/30/2014)... Chicago, IL (PRWEB) September 30, 2014 ... meet at the National Association of Health Advocacy Consultants ... of Healthcare Advocacyā€¯ (#NAHAC14) to be held October 30th ... Making its debut at NAHAC14: Standards and Best Practices ... advocacy grows into a profession, advocates have needed a ...
Breaking Medicine News(10 mins):Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Regenerative Medicine Solutions Expanding 2Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2
... 2012 - VIB researcher Diether Lambrechts, associated with KU ... which patients will benefit more from treatment with bevacizumab ... step towards personalized medicine and patient-tailored use of this ... Leuven) said "in two large clinical studies with patients ...
... symptoms of heart disease already have heart damage, according to ... Heart Failure Congress 2012 , 19-22 May, in Belgrade, Serbia. ... Failure Association of the European Society of Cardiology., ... research has shown that obese adults have structural and functional ...
... Reinberg HealthDay Reporter , FRIDAY, May 18 (HealthDay News) ... Americans born between 1945 and 1965 -- the baby boom generation ... deadly disease occur in this age group, and most were infected ... the agency said. "CDC views this as an unrecognized health ...
... combination of three drugs used worldwide as the standard of ... of death or hospitalization, and should not be used together ... the surprising results of a rigorous independent study. The ... New England Journal of Medicine to coincide with a ...
... For more than three decades, researchers have warned of ... tobacco smoke (ETS), especially among children whose parents smoke. ... University of Arizona reports that those health risks persist ... individuals end up becoming smokers later in life. ...
... , SATURDAY, May 19 (HealthDay News) -- More than ... more than half of those victims are younger than age ... (May 20 to 26), the American Academy of Pediatrics is ... Postal Service to educate people about dog safety. They ...
Cached Medicine News:Health News:Biomarker predicts response to cancer treatment 2Health News:Obese adolescents have heart damage 2Health News:Test Baby Boomers for Hepatitis C, Says CDC 2Health News:First, do no harm: Study finds danger in standard treatment for a serious lung disease 2Health News:First, do no harm: Study finds danger in standard treatment for a serious lung disease 3Health News:Study says children exposed to tobacco smoke face long-term respiratory problems 2Health News:Study says children exposed to tobacco smoke face long-term respiratory problems 3Health News:Keeping Your Family Safe From Dog Bites 2
(Date:9/30/2014)... 2014  Alimera Sciences, Inc. (NASDAQ: ALIM ... research, development and commercialization of prescription ophthalmic pharmaceuticals, announced ... from Hercules Technology Growth Capital, Inc. (NYSE: ... final advance under the Loan and Security Agreement that ... , Alimera Sciences Limited, entered into with Hercules in ...
(Date:9/30/2014)... 30, 2014 A study using a relatively ... new look at the composition of carotid artery disease ... and treat the disease, a leading cause of stroke. ... Lexington between September 2010 and May 2012, was featured ... of the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... , Sept. 30, 2014 Valeant Pharmaceuticals International, ... today announced that the company,s Bridgewater, New ... the U.S. Food and Drug Administration (FDA) relating to ... with regards to Sculptra Aesthetic injectable, which was divested ... to the management of Valeant,s contract manufacturers (rather than ...
Breaking Medicine Technology:Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
Research® Series 2100 Adjustable-volume Pipette, 0.5-10 µl, single-channel with adjustable-volume setting...
... Seven digital models cover the range from ... liquid fluently. Volume lock design prevents inadvertent ... the horizontal grip. Whole pipette is autoclavable ... ejector is all polypropylene. Suitable for one-handed ...
... The Finnpipette Digital offers improved ergonomics ... rounded handle, modified grippy finger rest ... operator comfort and efficiency. Finnpipette Digitals ... power-boosted gearing mechanism (pat. pend.) and ...
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
Medicine Products: